mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |